DLEU7 anticorps (AA 51-100)
Aperçu rapide pour DLEU7 anticorps (AA 51-100) (ABIN7228232)
Antigène
Reactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 51-100
-
Fonction
- Rabbit Anti-DLEU7 Polyclonal Antibody
-
Specificité
- The antibody detects endogenous levels of DLEU7
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogène
- Synthesized peptide derived from part region of human DLEU7 protein at AA range: 51-100
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC 1:50-200,ELISA 1:10000-20000,IF 1:50-200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
Date de péremption
- 12 months
-
-
- DLEU7 (Deleted in Lymphocytic Leukemia, 7 (DLEU7))
-
Autre désignation
- DLEU7
-
Sujet
- Leukemia-associated protein 7, Deleted in lymphocytic leukemia 7DLEU7, located adjacent to the consensus deleted region, and overlapping the 3' end of DLEU1 tail to tail. Human DLEU7 encodes a putative 221 amino acid protein, with significant conservation in rodents. Deletion of chromosome 13q14 is the most frequent genetic aberration in B-cell chronic lymphocytic leukemia (CLL), found in more than 50 % of cases, indicating that this region contains a gene(s) involved in the development of CLL.
-
ID gène
- 220107
-
UniProt
- Q6UYE1
Antigène
-